Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice

IF 8.8 1区 医学 Q1 CRITICAL CARE MEDICINE Critical Care Pub Date : 2024-12-28 DOI:10.1186/s13054-024-05215-4
Hiroyuki Ohbe, Kasumi Satoh, Takaaki Totoki, Atsushi Tanikawa, Kasumi Shirasaki, Yoshihide Kuribayashi, Miku Tamura, Yudai Takatani, Hiroyasu Ishikura, Kensuke Nakamura
{"title":"Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice","authors":"Hiroyuki Ohbe, Kasumi Satoh, Takaaki Totoki, Atsushi Tanikawa, Kasumi Shirasaki, Yoshihide Kuribayashi, Miku Tamura, Yudai Takatani, Hiroyasu Ishikura, Kensuke Nakamura","doi":"10.1186/s13054-024-05215-4","DOIUrl":null,"url":null,"abstract":"Medical advances in intensive care units (ICUs) have resulted in the emergence of a new patient population—those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms. This condition, often termed Persistent Critical Illness (PerCI) or Chronic Critical Illness (CCI), remains poorly understood and inconsistently reported across studies, resulting in a lack of clinical practice use. This scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on definitions, epidemiology, and outcomes for its translation to clinical practice. A scoping review was conducted using MEDLINE and Scopus, adhering to the PRISMA-ScR guidelines. Peer-reviewed original research articles published until May 31, 2024 that described adult PerCI/CCI in their definitions of patient populations, covariates, and outcomes were included. Data on definitions, epidemiology, and outcomes were extracted by a data charting process from eligible studies and synthesized. Ninety-nine studies met the inclusion criteria. Of these studies, 64 used the term CCI, 18 used PerCI, and 17 used other terms. CCI definitions showed greater variability, while PerCI definitions remained relatively consistent, with an ICU stay ≥ 14 days for CCI and ≥ 10 days for PerCI being the most common. A meta-analysis of the prevalence of PerCI/CCI among the denominators of “all ICU patients”, “sepsis”, “trauma”, and “COVID-19” showed 11% (95% confidence interval 10–12%), 28% (22–34%), 24% (15–33%), and 35% (20–50%), respectively. A meta-analysis of in-hospital mortality was 27% (26–29%) and that of one-year mortality was 45% (32–58%). Meta-analyses of the prevalence of CCI and PerCI showed 17% (16–18%) and 18% (16–20%), respectively, and those for in-hospital mortality were 28% (26–30%) and 26% (24–29%), respectively. Functional outcomes were generally poor, with many survivors requiring long-term care. This scoping review synthesized many studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients’ long-term outcomes. The results obtained underscore the need for consistent terminology with high-quality research for PerCI/CCI. The results obtained provide important information to be used in discussions with patients and families regarding prognosis and care options. ","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"32 1","pages":""},"PeriodicalIF":8.8000,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13054-024-05215-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Medical advances in intensive care units (ICUs) have resulted in the emergence of a new patient population—those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms. This condition, often termed Persistent Critical Illness (PerCI) or Chronic Critical Illness (CCI), remains poorly understood and inconsistently reported across studies, resulting in a lack of clinical practice use. This scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on definitions, epidemiology, and outcomes for its translation to clinical practice. A scoping review was conducted using MEDLINE and Scopus, adhering to the PRISMA-ScR guidelines. Peer-reviewed original research articles published until May 31, 2024 that described adult PerCI/CCI in their definitions of patient populations, covariates, and outcomes were included. Data on definitions, epidemiology, and outcomes were extracted by a data charting process from eligible studies and synthesized. Ninety-nine studies met the inclusion criteria. Of these studies, 64 used the term CCI, 18 used PerCI, and 17 used other terms. CCI definitions showed greater variability, while PerCI definitions remained relatively consistent, with an ICU stay ≥ 14 days for CCI and ≥ 10 days for PerCI being the most common. A meta-analysis of the prevalence of PerCI/CCI among the denominators of “all ICU patients”, “sepsis”, “trauma”, and “COVID-19” showed 11% (95% confidence interval 10–12%), 28% (22–34%), 24% (15–33%), and 35% (20–50%), respectively. A meta-analysis of in-hospital mortality was 27% (26–29%) and that of one-year mortality was 45% (32–58%). Meta-analyses of the prevalence of CCI and PerCI showed 17% (16–18%) and 18% (16–20%), respectively, and those for in-hospital mortality were 28% (26–30%) and 26% (24–29%), respectively. Functional outcomes were generally poor, with many survivors requiring long-term care. This scoping review synthesized many studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients’ long-term outcomes. The results obtained underscore the need for consistent terminology with high-quality research for PerCI/CCI. The results obtained provide important information to be used in discussions with patients and families regarding prognosis and care options.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
定义,流行病学,和持续性/慢性危重疾病的结果:翻译到临床实践的范围审查
重症监护室(ICU)的医学进步导致了一个新的患者群体的出现——那些在危重疾病的初始急性期存活下来,但需要延长ICU住院时间并出现慢性危重症状的患者。这种情况,通常被称为持续性危重疾病(PerCI)或慢性危重疾病(CCI),在研究中仍然知之甚少,报告不一致,导致缺乏临床实践使用。本综述旨在系统地回顾和综合现有的关于ci /CCI的文献,重点关注其定义、流行病学和临床应用的结果。根据PRISMA-ScR指南,使用MEDLINE和Scopus进行范围审查。在2024年5月31日之前发表的同行评审的原创研究文章中,描述了成人的ci /CCI在患者群体、协变量和结果的定义。定义、流行病学和结果的数据通过数据图表过程从符合条件的研究中提取并综合。99项研究符合纳入标准。在这些研究中,64个使用CCI, 18个使用PerCI, 17个使用其他术语。CCI的定义具有较大的可变性,而ci的定义保持相对一致,CCI≥14天和ci≥10天是最常见的。对“所有ICU患者”、“败血症”、“创伤”和“COVID-19”等指标的ci /CCI患病率进行meta分析,分别为11%(95%可信区间为10-12%)、28%(22-34%)、24%(15-33%)和35%(20-50%)。一项荟萃分析显示,住院死亡率为27%(26-29%),一年死亡率为45%(32-58%)。CCI和PerCI的患病率分别为17%(16-18%)和18%(16-20%),住院死亡率分别为28%(26-30%)和26%(24-29%)。功能预后通常较差,许多幸存者需要长期护理。本综述综合了许多关于PerCI/CCI的研究,强调了PerCI/CCI对患者长期预后的严重影响。所获得的结果强调需要与高质量研究一致的术语。获得的结果提供了重要的信息,用于与患者和家属讨论预后和护理方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Critical Care
Critical Care 医学-危重病医学
CiteScore
20.60
自引率
3.30%
发文量
348
审稿时长
1.5 months
期刊介绍: Critical Care is an esteemed international medical journal that undergoes a rigorous peer-review process to maintain its high quality standards. Its primary objective is to enhance the healthcare services offered to critically ill patients. To achieve this, the journal focuses on gathering, exchanging, disseminating, and endorsing evidence-based information that is highly relevant to intensivists. By doing so, Critical Care seeks to provide a thorough and inclusive examination of the intensive care field.
期刊最新文献
Enhancing cultural competence and communication in ICU: addressing family conflicts Ulinastatin treatment mitigates glycocalyx degradation and associated with lower postoperative delirium risk in patients undergoing cardiac surgery: a multicentre observational study Association of healthy sleep patterns with incident sepsis: a large population-based prospective cohort study Heterogeneity of treatment effect: the case for individualising oxygen therapy in critically ill patients Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1